Nathalie E Synhaeve1, Cees van der Heul, Cees C Tijssen. Show Affiliations » 1. Department of Neurology, St Elisabeth Hospital, Tilburg, Netherlands. n.synhaeve@elisabeth.nl
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useAntineoplastic Agents, Alkylating/administration & dosageAntineoplastic Agents, Alkylating/therapeutic useBoronic Acids/adverse effectsBoronic Acids/therapeutic useBortezomibBrain Neoplasms/diagnosisBrain Neoplasms/drug therapyDexamethasone/administration & dosageDexamethasone/therapeutic useDrug Therapy, CombinationHumansMagnetic Resonance ImagingMaleMelphalan/administration & dosageMelphalan/therapeutic useMultiple Myeloma/diagnosisMultiple Myeloma/drug therapyPyrazines/adverse effectsPyrazines/therapeutic useTreatment Outcome
Substances: See more » Antineoplastic AgentsAntineoplastic Agents, AlkylatingBoronic AcidsPyrazinesBortezomibDexamethasoneMelphalan
Year: 2012 PMID: 23035155 PMCID: PMC4542812 DOI: 10.1136/bcr.03.2012.5964
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X